Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.335 USD | +3.57% | +1.26% | +119.28% |
Apr. 17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
Apr. 10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+119.28% | 846M | |
+24.63% | 46.71B | |
+48.83% | 41.8B | |
-1.14% | 41.52B | |
-3.42% | 29.55B | |
+10.61% | 25.78B | |
-21.18% | 19.26B | |
+0.71% | 12.14B | |
-3.10% | 12.08B | |
+26.84% | 11.98B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment